Guillain-Barré syndrome in a patient on adalimumab for the treatment of psoriasis
An. bras. dermatol
;
92(5,supl.1): 85-87, 2017. tab
Article
in English
| LILACS
| ID: biblio-887079
ABSTRACT
Abstract The use of TNF-α inhibitors for the treatment of moderate to severe psoriasis and psoriatic arthritis is increasingly more frequent. The authors report a case of Guillain-Barré syndrome as a late manifestation of the treatment with adalimumab. Although unusual, this is relevant for professionals who prescribe biologic drugs. We also stress the importance of investigating the past and family medical history regarding demyelinating diseases before starting treatment.
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Psoriasis
/
Lymphotoxin-alpha
/
Guillain-Barre Syndrome
/
Adalimumab
/
Anti-Inflammatory Agents
Limits:
Humans
/
Male
Language:
English
Journal:
An. bras. dermatol
Journal subject:
Dermatology
Year:
2017
Type:
Article
Affiliation country:
Brazil
Institution/Affiliation country:
Hospital Naval Marcílio Dias/BR
Similar
MEDLINE
...
LILACS
LIS